|
Hurwitz, S J; Ma, L; Eleuteri, A et al. (2000) Cellular pharmacology of the D- and L-enantiomers of beta-5-o-carboranyl-2'-deoxyuridine. Nucleosides Nucleotides Nucleic Acids 19:691-702
|
|
Graciet, J C; Shi, J; Schinazi, R F (1998) Synthesis and biological properties of the four optical isomers of 5-o-carboranyl-2',3'-didehydro-2',3'-dideoxyuridine. Nucleosides Nucleotides 17:711-27
|
|
Lesnikowski, Z J; Fulcrand, G; Lloyd Jr, R M et al. (1996) Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2'-deoxyuridine. Biochemistry 35:5741-6
|
|
Schinazi, R F; Goudgaon, N M; Fulcrand, G et al. (1994) Cellular pharmacology and biological activity of 5-carboranyl-2'-deoxyuridine. Int J Radiat Oncol Biol Phys 28:1113-20
|
|
Jarugula, V R; Schinazi, R F; Fulcrand, G et al. (1994) Pharmacokinetics of 5-carboranyl-2'-deoxyuridine in rats. J Pharm Sci 83:1697-9
|
|
Fulcrand-el Kattan, G; Goudgaon, N M; Ilksoy, N et al. (1994) Synthesis and biological properties of 5-o-carboranyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil. J Med Chem 37:2583-8
|
|
Goudgaon, N M; Naguib, F N; el Kouni, M H et al. (1993) Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase. J Med Chem 36:4250-4
|
